Skip Navigation



Bioinformatics Advance Access published online on August 7, 2006

Bioinformatics, doi:10.1093/bioinformatics/btl424
This Article
Right arrow Advance Access manuscript (PDF) Freely available
Right arrow Supplementary Material
Right arrowOA All Versions of this Article:
22/20/2500    most recent
btl424v1
Right arrow Comments: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Comments are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Manoli, T.
Right arrow Articles by Brors, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Manoli, T.
Right arrow Articles by Brors, B.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2006 The Author(s)
Received March 8, 2006
Revised July 22, 2006
Accepted July 28, 2006

Article

Group testing for pathway analysis improves comparability of different microarray data sets

Theodora Manoli 1, Norbert Gretz 2, Hermann-Josef Gröne 3, Marc Kenzelmann 3, Roland Eils 4, and Benedikt Brors 4 *

1 Theoretical Bioinformatics, German Cancer Reseach Center, 69120 Heidelberg, Germany; Medical Research Center, University Hospital Mannheim, 68167 Mannheim, Germany; Cellular and Molecular Pathology, German Cancer Research Center, 69120 Heidelberg, Germany
2 Medical Research Center, University Hospital Mannheim, 68167 Mannheim, Germany
3 Cellular and Molecular Pathology, German Cancer Research Center, 69120 Heidelberg, Germany
4 Theoretical Bioinformatics, German Cancer Reseach Center, 69120 Heidelberg, Germany

* To whom correspondence should be addressed.
Benedikt Brors, E-mail: b.brors{at}dkfz.de


   Abstract

Motivation: The wide use of DNA microarrays for the investigation of the cell transcriptome triggered the invention of numerous methods for the processing of microarray data and lead to a growing number of microarray studies that examine the same biological conditions. However, comparisons made on the level of gene lists obtained by different statistical methods or from different data sets hardly converge. We aimed at examining such discrepancies on the level of apparently affected biologically related groups of genes, for example metabolic or signalling pathways. This can be achieved by group testing procedures, e.g. over-representation analysis (ORA), bluefunctional class scoring (FCS), or global tests.

Results: Three public prostate cancer data sets obtained with the same microarray platform (HGU95A/HGU95av2) were analyzed. Each data set was subjected to normalization by either variance stabilizing normalization (vsn) or mixed model normalization (MMN). Then, statistical analysis of microarrays (SAM) was applied to the vsn-normalized data and mixed model analsis (MMA) to the data normalized by MMN. For multiple testing adjustment the false discovery rate (FDR) was calculated and the threshold was set to 0.05. Gene lists from the same method applied to different data sets showed overlaps between 42% and 52%, while lists from different methods applied to the same data set had between 63% and 85% of genes in common. A number of six gene lists obtained by the two statistical methods applied to the three data sets was then subjected to group testing by blueFisher's exact test. Group testing by GSEA and global test was applied to the three data sets, as well. Fisher's exact test followed by global test showed more consistent results with respect to the concordance between analyses on gene lists obtained by different methods and different data sets than the GSEA. However, all group testing methods identified pathways that had already been described to be involved in the pathogenesis of prostate cancer. Moreover, pathways recurrently identified in these analyses are more likely to be reliable than those from a single analysis on a single data set.

Supplementary Info: Supplementary Figure 1 and Supplementary Tables 1-4 are available from the Journal's website.


Associate Editor: David Rocke
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
BioinformaticsHome page
Y. Lu, P. Huggins, and Z. Bar-Joseph
Cross species analysis of microarray expression data
Bioinformatics, June 15, 2009; 25(12): 1476 - 1483.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
H. S. Leong and D. Kipling
Text-based over-representation analysis of microarray gene lists with annotation bias
Nucleic Acids Res., June 1, 2009; 37(11): e79 - e79.
[Abstract] [Full Text] [PDF]


Home page
Brief Funct Genomic ProteomicHome page
N. S. Nagaraj
Evolving 'omics' technologies for diagnostics of head and neck cancer
Brief Funct Genomic Proteomic, March 9, 2009; (2009) elp004v1.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
N. Neretti, P.-Y. Wang, A. S. Brodsky, H. H. Nyguyen, K. P. White, B. Rogina, and S. L. Helfand
Long-lived Indy induces reduced mitochondrial reactive oxygen species production and oxidative damage
PNAS, February 17, 2009; 106(7): 2277 - 2282.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
B. Sanchez-Espiridion, A. Sanchez-Aguilera, C. Montalban, C. Martin, R. Martinez, J. Gonzalez-Carrero, C. Poderos, C. Bellas, M. F. Fresno, C. Morante, et al.
A TaqMan Low-Density Array to Predict Outcome in Advanced Hodgkin's Lymphoma Using Paraffin-Embedded Samples
Clin. Cancer Res., February 15, 2009; 15(4): 1367 - 1375.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
N. P. Smirnova, A. A. Ptitsyn, K. J. Austin, H. Bielefeldt-Ohmann, H. Van Campen, H. Han, A. L. van Olphen, and T. R. Hansen
Persistent fetal infection with bovine viral diarrhea virus differentially affects maternal blood cell signal transduction pathways
Physiol Genomics, February 2, 2009; 36(3): 129 - 139.
[Abstract] [Full Text] [PDF]


Home page
BioinformaticsHome page
X. Chen, L. Wang, J. D. Smith, and B. Zhang
Supervised principal component analysis for gene set enrichment of microarray data with continuous or survival outcomes
Bioinformatics, November 1, 2008; 24(21): 2474 - 2481.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
I. Zschiedrich, U. Hardeland, A. Krones-Herzig, M. Berriel Diaz, A. Vegiopoulos, J. Muggenburg, D. Sombroek, T. G. Hofmann, R. Zawatzky, X. Yu, et al.
Coactivator function of RIP140 for NF{kappa}B/RelA-dependent cytokine gene expression
Blood, July 15, 2008; 112(2): 264 - 276.
[Abstract] [Full Text] [PDF]


Home page
Brief BioinformHome page
D. Nam and S.-Y. Kim
Gene-set approach for expression pattern analysis
Brief Bioinform, May 1, 2008; 9(3): 189 - 197.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
D. Shriner, T. M. Baye, M. A. Padilla, S. Zhang, L. K. Vaughan, and A. E. Loraine
Commonality of functional annotation: a method for prioritization of candidate genes from genome-wide linkage studies
Nucleic Acids Res., March 27, 2008; 36(4): e26 - e26.
[Abstract] [Full Text] [PDF]


Home page
BioinformaticsHome page
M. Hummel, R. Meister, and U. Mansmann
GlobalANCOVA: exploration and assessment of gene group effects
Bioinformatics, January 1, 2008; 24(1): 78 - 85.
[Abstract] [Full Text] [PDF]


Home page
BioinformaticsHome page
X. Xu, Y. Zhao, and R. Simon
Gene Set Expression Comparison kit for BRB-ArrayTools
Bioinformatics, January 1, 2008; 24(1): 137 - 139.
[Abstract] [Full Text] [PDF]


Home page
BioinformaticsHome page
J. J. Goeman and P. Buhlmann
Analyzing gene expression data in terms of gene sets: methodological issues
Bioinformatics, April 15, 2007; 23(8): 980 - 987.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.